First and only registered organization to receive Schedule I controlled substance manufacturing and export licenses from the New York State Department of Health Licenses represent important milestones in process to complete US federal DEA Schedule I bulk manufacturing and export license review and

Company’s board of directors approves $25 million open market repurchase program NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (NEO:CCHW) (OTCQX:CCHWF) (FSE:3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses

Columbia Care now trades under the following ticker symbols: “CCHW” on the NEO Exchange in Canada for CAD denominated shares; “CCHWF” on the OTCQX® Best Market in the United States for USD denominated shares; “3LP” on the Frankfurt Stock Exchange in Germany for Euro denominated shares NEW

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO: CCHW, OTCQX: CCHWF, FSE: 3LP), one of the largest fully-integrated operators in the global medical cannabis industry with licenses across the US and the EU, is pleased to announce that its Euro denominated

NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc. (“Columbia Care” or the “Company”) (NEO: CCHW, OTCQX: COLXF), one of the largest fully-integrated operators in the global medical cannabis industry with licenses across the US and the EU, is pleased to announce that its US dollar denominated shares

One of only 17 large-scale Level I cultivation licenses granted after highly selective award process State-of-the-art cultivation facility receives Certificate of Operation to begin supplying state licensed distributors and manufacturers in the seventh most populous US market with

Global Medical cannabis leader expands dispensary footprint to Gainesville, one of Florida’s most densely populated metropolitan areas and provides update on new cultivation and manufacturing facility Gainesville dispensary to provide differentiated product offering with portfolio of proprietary,

Global medical cannabis leader launches west coast expansion plan in California’s largest, limited license metropolitan market Nationally proven high-touch, provider-based dispensary model and proprietary pharmaceutical-quality products bring novel, impactful and personalized cannabis-based health

First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to support optimal product dosing and formulation selection NEW YORK--(BUSINESS WIRE)-- Columbia Care Inc.

Currently available in multiple markets, the CNC card will enable cannabis consumers and dispensaries nationwide to transact electronically using credit in all of Columbia Care’s markets by the end of 2019 First legal, transparent and highly scalable credit card solution available to fast-growing